Mortality in diastolic heart failure: An update

Cardiology in Review

Volumn 17, Issue 2, 2009, Pages 51-55

  Fitzgibbons, Timothy P ^a   Meyer, Theo E ^a   Aurigemma, Gerard P ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANDESARTAN; PLACEBO;

CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIASTOLIC HEART FAILURE; DIFFERENTIAL DIAGNOSIS; ECHOCARDIOGRAPHY; HEART EJECTION FRACTION; HUMAN; HYPERTENSION; MORBIDITY; MORTALITY; OBESITY; PREVALENCE; REVIEW; RISK FACTOR; SURVIVAL RATE; SYSTOLIC HEART FAILURE; UNITED STATES;

CARDIOTONIC AGENTS; DIAGNOSIS, DIFFERENTIAL; HEART FAILURE, DIASTOLIC; HEART FAILURE, SYSTOLIC; HUMANS; PREVALENCE; UNITED STATES;

EID: 67649949109     PISSN: 10615377     EISSN: None     Source Type: Journal    
DOI: 10.1097/CRD.0b013e318194527d     Document Type: Review

References (33)

1. Thom T, Haase N, Rosamond W, et al. Heart disease and stroke statistics -2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006;113:85-151.
2. Owan TE, Hodge DO, Herges RM, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355: 251-259.
3. Bhatia RS, Tu JV, Lee DS, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006;355:260-269.
4. Klapholz M, Maurer M, Lowe AM, et al. Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry. J Am Coll Cardiol. 2004;43:432-438.
5. Gaasch WH, Zile MR. Diastolic dysfunction and diastolic heart failure. Annu Rev Med. 2004;55:373-394.
6. Redfield MM, Jacobsen SJ, Burnett JC Jr, et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003;289:194-202.
7. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure. Part I. Diagnosis, prognosis, and measurements of diastolic function. Circulation. 2002;105:1387-1393.
8. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure. Part II. Causal mechanisms and treatment. Circulation. 2002; 105:1503-1508.
9. Hunt SA, Abraham WT, Yancy CW, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult. J Am Coll Cardiol. 2005;46:e1-e82.
10. Lester SJ, Tajik AJ, Nishimura RA, et al. Unlocking the mysteries of diastolic function: deciphering the Rosetta Stone 10 years later. J Am Coll Cardiol. 2008;51:679-689.
11. Vasan R, Larson MG, Benjamin EJ, et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol. 1999;33:1948- 1955.
12. Owan TE, Redfield MM. Epidemiology of diastolic heart failure. Prog Cardiovasc Dis. 2005;47:320-332.
13. Bursi F, Weston SA, Redfield MM, et al. Systolic and diastolic heart failure in the community. JAMA. 2006;296:2209-2216.
14. Aurigemma GP, Gottdiener JS, Shemanski L, et al. Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol. 2001;37:1042- 1048.
15. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997;157:2413-2446.
16. Chobanian A, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. JAMA. 2003;289:2566-2572.
17. Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of candesartan in patients with heart failure and preserved left-ventricular ejection fraction: the CHARM-preserved trial. Lancet. 2003;362:777-781.
18. Smith GL, Masoudi FA, Vaccarino V, et al. Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline. J Am Coll Cardiol. 2003;41:1510-1508.
19. Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation. 1998;98:2282-2289.
20. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997;336:525-533.
21. Cohn JN, Johnson G. Heart failure with normal ejection fraction. The V-HeFT study. Circulation. 1990;81:48-53.
22. Gottdiener JS, McClelland RL, Marshall R, et al. Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study. Ann Intern Med. 2002;137:631-639.
23. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7:79-108.
24. Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002;347:1397-1402.
25. Gheorghiade M, Abraham WT, Albert NM, et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA. 2006;296:2217-2226.
26. Philbin EF, Rocco TA, Lidenmath NW, et al. Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin- converting enzyme inhibitors. Am J Med. 2000;109:605-613.
27. Solomon SD, Dobson J, Pocock S, et al. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation. 2007;116:1482-1487.
28. Solomon SD, Anavekar N, Skali H, et al. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation. 2005;112:3738-3744.
29. Ahmed A, Rich MW, Fleg JL, et al. Effects of digoxin on morbidity and mortality in diastolic heart failure: the Ancillary Digitalis Investigation Group Trial. Circulation. 2006;114:397-403.
30. McMurray J, Carson PE, Komajda M, et al. Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial. Eur J Heart Fail. 2008;10:149-156.
31. American Cancer Society. Cancer Facts & Figures 2007. Atlanta, GA: American Cancer Society; 2007. Available at: http://www.cancer.org/ docroot/stt/stt-0.asp.
32. Kostis WJ, Demissie K, Marcella SW, et al. Weekend versus weekday admission and mortality from myocardial infarction. N Engl J Med. 2007; 356:1099-1109.
33. Solomon SD, Janardhanan R, Verma A, et al. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a Randomized Trial. Lancet. 2007; 369:2079-2087.